ntrospective Market Research (IMR) has published its latest forecast for the Global Alpha Emitter Market , projecting substantial growth through the end of the decade. According to the report, the market was valued at USD 1.30 billion in 2023 and is expected to grow to USD 3.09 billion by 2032 , representing a compound annual growth rate (CAGR) of 10.10% during the 2024–2032 period. This...

"Executive Summary Colorectal Cancer Treatment Market Size and Share: Global Industry Snapshot  Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Research and analysis about the key...

Introspective Market Research, a global leader in advanced market analysis, today unveiled its comprehensive report on the Global Immunotherapy Drugs Market v. The market is experiencing a paradigm shift in therapeutic strategy, moving away from conventional treatments towards approaches that leverage the body's own defense mechanisms to combat complex diseases. The Immunotherapy Drugs Market...

"Global Executive Summary RNA Therapeutics Market: Size, Share, and Forecast During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine   While preparing the first class RNA Therapeutics...

"Regional Overview of Executive Summary Medical Cyclotron Market by Size and Share The global medical cyclotron market size was valued at USD 228.20 million in 2025 and is expected to reach USD 466.85 million by 2033, at a CAGR of 9.36% during the forecast period     With the superior Medical Cyclotron Market report, get knowledge...

Introspective Market Research, a key leader in providing analytical market intelligence, today released its in-depth report on the Global Solid Tumor Testing Market . This critical market segment encompasses the entire suite of diagnostic products, technologies, and services used to identify, stage, and manage solid tumors—malignant neoplasms found in organs such as the lung, breast,...